Literature DB >> 19953625

Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations.

Ellen Denayer1, Koen Devriendt, Thomy de Ravel, Griet Van Buggenhout, Eric Smeets, Inge Francois, Yves Sznajer, Margarita Craen, George Leventopoulos, Léon Mutesa, Willy Vandecasseye, Guy Massa, Hulya Kayserili, Raf Sciot, Jean-Pierre Fryns, Eric Legius.   

Abstract

Noonan syndrome (NS) is an autosomal dominant disorder caused by mutations in PTPN11, KRAS, SOS1, and RAF1. We performed SOS1, RAF1, BRAF, MEK1, and MEK2 mutation analysis in a cohort of 102 PTPN11- and KRAS-negative NS patients and found pathogenic SOS1 mutations in 10, RAF1 mutations in 4, and BRAF mutations in 2 patients. Three novel SOS1 mutations were found. One was classified as a rare benign variant and the other remains unclassified. We confirm a high prevalence of pulmonic stenosis and ectodermal abnormalities in SOS1-positive patients. Three patients with SOS1 mutations presented with tumors (embryonal rhabdomyosarcoma, Sertoli cell testis tumor, and granular cell tumors of the skin). One patient with a RAF1 mutation had a lesion suggestive for a giant cell tumor. This is the first report describing different tumor types in NS patients with germ line SOS1 mutations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19953625     DOI: 10.1002/gcc.20735

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  23 in total

1.  Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.

Authors:  Masako Yaoita; Tetsuya Niihori; Seiji Mizuno; Nobuhiko Okamoto; Shion Hayashi; Atsushi Watanabe; Masato Yokozawa; Hiroshi Suzumura; Akihiko Nakahara; Yusuke Nakano; Tatsunori Hokosaki; Ayumi Ohmori; Hirofumi Sawada; Ohsuke Migita; Aya Mima; Pablo Lapunzina; Fernando Santos-Simarro; Sixto García-Miñaúr; Tsutomu Ogata; Hiroshi Kawame; Kenji Kurosawa; Hirofumi Ohashi; Shin-Ichi Inoue; Yoichi Matsubara; Shigeo Kure; Yoko Aoki
Journal:  Hum Genet       Date:  2015-12-29       Impact factor: 4.132

2.  Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.

Authors:  Yoko Aoki; Tetsuya Niihori; Toshihiro Banjo; Nobuhiko Okamoto; Seiji Mizuno; Kenji Kurosawa; Tsutomu Ogata; Fumio Takada; Michihiro Yano; Toru Ando; Tadataka Hoshika; Christopher Barnett; Hirofumi Ohashi; Hiroshi Kawame; Tomonobu Hasegawa; Takahiro Okutani; Tatsuo Nagashima; Satoshi Hasegawa; Ryo Funayama; Takeshi Nagashima; Keiko Nakayama; Shin-Ichi Inoue; Yusuke Watanabe; Toshihiko Ogura; Yoichi Matsubara
Journal:  Am J Hum Genet       Date:  2013-06-20       Impact factor: 11.025

3.  New Genetic Insights into Congenital Heart Disease.

Authors:  Stephanie M Ware; John Lynn Jefferies
Journal:  J Clin Exp Cardiolog       Date:  2012-06-15

Review 4.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

Review 5.  Growth hormone, the insulin-like growth factor axis, insulin and cancer risk.

Authors:  Peter E Clayton; Indraneel Banerjee; Philip G Murray; Andrew G Renehan
Journal:  Nat Rev Endocrinol       Date:  2010-10-19       Impact factor: 43.330

Review 6.  Ras/MAPK syndromes and childhood hemato-oncological diseases.

Authors:  Yoko Aoki; Yoichi Matsubara
Journal:  Int J Hematol       Date:  2012-12-19       Impact factor: 2.490

Review 7.  Syndrome-Associated Tumors by Organ System.

Authors:  Raul S Gonzalez; Nicole D Riddle
Journal:  J Pediatr Genet       Date:  2016-03-09

8.  Correlation between oncological family history and clinical outcome in a large monocentric cohort of pediatric patients with rhabdomyosarcoma.

Authors:  Patrizia Gasparini; Andrea Ferrari; Valentina Sottili; Stefano Signoroni; Francesco Barretta; Jacopo Azzollini; Siranoush Manoukian; Roberto Luksch; Monica Terenziani; Michela Casanova; Filippo Spreafico; Cristina Meazza; Marta Podda; Veronica Biassoni; Elisabetta Schiavello; Stefano Chiaravalli; Maura Massimino
Journal:  Int J Clin Oncol       Date:  2021-06-01       Impact factor: 3.402

9.  Comparative assessment of gene-specific variant distribution in prenatal and postnatal cohorts tested for Noonan syndrome and related conditions.

Authors:  N T Leach; D R Wilson Mathews; L S Rosenblum; Z Zhou; H Zhu; R A Heim
Journal:  Genet Med       Date:  2018-06-15       Impact factor: 8.822

10.  Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome.

Authors:  Viviana Cordeddu; Jiani C Yin; Cecilia Gunnarsson; Carl Virtanen; Séverine Drunat; Francesca Lepri; Alessandro De Luca; Cesare Rossi; Andrea Ciolfi; Trevor J Pugh; Alessandro Bruselles; James R Priest; Len A Pennacchio; Zhibin Lu; Arnavaz Danesh; Rene Quevedo; Alaa Hamid; Simone Martinelli; Francesca Pantaleoni; Maria Gnazzo; Paola Daniele; Christina Lissewski; Gianfranco Bocchinfuso; Lorenzo Stella; Sylvie Odent; Nicole Philip; Laurence Faivre; Marketa Vlckova; Eva Seemanova; Cristina Digilio; Martin Zenker; Giuseppe Zampino; Alain Verloes; Bruno Dallapiccola; Amy E Roberts; Hélène Cavé; Bruce D Gelb; Benjamin G Neel; Marco Tartaglia
Journal:  Hum Mutat       Date:  2015-08-03       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.